FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/BIO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bio-Rad Laboratories (BIO) trades at $367.50, down 1.98% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q2 and Q3 2026 earnings beats but faces valuation concerns with a P/E of 46.28. Recent partnerships in identity security and digital PCR technology expansion highlight growth initiatives, while institutional ownership remains substantial with CalSTRS holding a $1.79 billion position as of Q2 2026.
BIO presents a balanced risk-reward profile with analyst consensus favoring Buy (57%) but a price target below current levels. Strong cash flow generation and margin improvement targets support upside potential, though high valuation and China market risks warrant caution. The stock's trajectory hinges on execution of margin expansion and international growth strategies amid competitive pressures.
Read full analysis

Key Stats

  • Market Cap
    $10.16B
  • Volume
    281,796
  • Sector
    Health
  • 52W High
    $390.34
  • 52W Low
    $241.71
  • Typical Hold Time
    61 Days
  • Enterprise Value
    $9.91B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$367.42
52W Low: $241.71
12 May 2026
52W High: $390.34
25 Aug 2026

Track Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class A Common Stock has traded between a low of $241.71 and a high of $390.34, highlighting its annual price range. Buy and sell Bio-Rad Laboratories, Inc. Class A Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Most Recent News

Content is generated by Aura AI

Dune completes SOC 2 Type II, boosting trust as tokenized assets hit $32.6B amid growing institutional blockchain use.

Dune has completed a SOC 2 Type II examination with no exceptions, providing institutional clients with verified assurance of its data security standards. This milestone comes as tokenized real-world assets doubled to $32.6 billion and stablecoin mar...

Market News
1 hour ago
Not Specified
Bullish
news icon
Dune completes SOC 2 Type II, boosting trust as tokenized assets hit $32.6B amid growing institutional blockchain use.

Opus Genetics completes dosing in Phase 1/2 trial for gene therapy targeting inherited retinal diseases

Opus Genetics has finished dosing the higher-dose Cohort 2 in its Phase 1/2 trial of OPGx-BEST1, a gene therapy for BEST1-related inherited retinal diseases like Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Cohort 2 en...

Market News
2 hours ago
Na
Bullish
news icon
Opus Genetics completes dosing in Phase 1/2 trial for gene therapy targeting inherited retinal diseases

Purple renews WiFi partnership with Lucid Motors in Riyadh, enhancing connectivity for staff and visitors.

Purple has renewed its partnership with Lucid Motors to continue providing WiFi services across Lucid's operations in Riyadh. This renewal ensures that both staff and visitors have secure and easy internet access, supporting Lucid's growing presence ...

Market News
4 hours ago
Purple Press Team
Bullish
news icon
Purple renews WiFi partnership with Lucid Motors in Riyadh, enhancing connectivity for staff and visitors.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $10.16B
  • Volume
    281,796
  • Sector
    Health
  • 52W High
    $390.34
  • 52W Low
    $241.71
  • Typical Hold Time
    61 Days
  • Enterprise Value
    $9.91B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$367.42
52W Low: $241.71
12 May 2026
52W High: $390.34
25 Aug 2026

Track Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class A Common Stock has traded between a low of $241.71 and a high of $390.34, highlighting its annual price range. Buy and sell Bio-Rad Laboratories, Inc. Class A Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!